DAVP-1 (Cat No.: I025557) is a synthetic analog of vasopressin, designed to selectively activate vasopressin V2 receptors. It is primarily used in research to study water reabsorption mechanisms in the kidneys and to explore treatments for conditions like diabetes insipidus and hyponatremia. By stimulating V2 receptors, DAVP-1 promotes the insertion of aquaporin-2 channels into renal tubules, enhancing water retention. Its receptor selectivity and stability make it a valuable tool for dissecting vasopressin signaling pathways and evaluating potential therapeutic strategies targeting water balance disorders.
Synonyms | DAVP-1; DAVP 1; DAVP1; |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 4-dimethylamino-6-vinylpyrimidine |
InChI | InChI=1S/C8H11N3/c1-4-7-5-8(11(2)3)10-6-9-7/h4-6H,1H2,2-3H3 |
InChIKey | GFZDHKFQHAEMGL-UHFFFAOYSA-N |
SMILES | C=CC1=CC(N(C)C)=NC=N1 |
Reference | 1: La J, Latham CF, Tinetti RN, Johnson A, Tyssen D, Huber KD, Sluis-Cremer N, |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |